Company Profile · Healthcare

Waters Corporation

WAT · US
Exchange
US
Country
USA
IPO date
Nov 16, 1995
Employees
16,000
Current Price
$355.44
Live · Jun 18, 2026
Fair Buy
≤ $240
Margin-of-safety entry
Baillie Growth Score
46/100
Weak
Intrinsic Value · Three-Tier Range Current price $355.44 Live · Within the optimistic intrinsic-value range · much expectation priced in

Composite valuation range · conservative $170–$220 / fair $230–$300 / optimistic $320–$380. At $355.44, Within the optimistic intrinsic-value range · much expectation priced in.

At publication $342.18 (May 28, 2026)

No reports on this stock in your language yet.

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Market cap$35.05B
Revenue (TTM)$3.77B
EBITDA$1.14B
Profit margin11.93%
ROE5.21%
P/E (TTM)45.42
Forward P/E24.94
PEG1.6
EPS$7.86
52-week range$275.05 – $414.15
Analyst target$400.27
Analyst rating3.6 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.